Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

April 06, 2015; 84 (14 Supplement) April 21, 2015

Assessing Migraine: An Enquiry into Prophylactic Treatment Patterns by Diagnosis: The AMEND Study (P3.042)

Anoop Reddy, Amanda Policastro, Albert Reppine, John Sekab, Chris Purdy, Laura Dalfonso, Raf Magar
First published April 8, 2015,
Anoop Reddy
4Anoop Reddy Private Practice Tampa FL United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda Policastro
3Allergan, Inc. Irvine CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert Reppine
3Allergan, Inc. Irvine CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Sekab
3Allergan, Inc. Irvine CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chris Purdy
1AHRM Inc. Buffalo NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Dalfonso
2AHRM, Inc. Buffalo NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raf Magar
2AHRM, Inc. Buffalo NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
Assessing Migraine: An Enquiry into Prophylactic Treatment Patterns by Diagnosis: The AMEND Study (P3.042)
Anoop Reddy, Amanda Policastro, Albert Reppine, John Sekab, Chris Purdy, Laura Dalfonso, Raf Magar
Neurology Apr 2015, 84 (14 Supplement) P3.042;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
0

Share

  • Article
  • Info & Disclosures
Loading

Abstract

OBJECTIVE:To assess the prophylactic treatment patterns for migraine patients diagnosed and not diagnosed with chronic migraine (CM). BACKGROUND: Current prophylactic management of migraine includes a variety of concomitantly prescribed treatments. Existing research indicates migraine disorders may be underdiagnosed. DESIGN/METHODS: Retrospective medical records were reviewed for patients with CM and Non-CM headache diagnoses (NCT01946126). Qualifying medical records were required to have 蠅 2 visits during the 15-month period. Patients were required to have at least one visit with a minimum of 8 headache days per 30-day period. Prophylactic medication records were collected at the first visit (FV) and most recent visit (MRV). Evaluable headache day records were collected throughout the study. RESULTS: Medical records from 459 patients qualified and were analyzed. Of these patients, 40[percnt] had a diagnosis of CM, and 60[percnt] had a Non-CM diagnosis. Of the Non-CM patients, 96[percnt] had a migraine diagnosis, while 4[percnt] had other headache diagnoses. A majority of the Non-CM population (55[percnt]) reported at least one visit with 蠅 15 headache days. During the study period, 68 patients had a change in diagnosis to CM. Migraine prophylaxis increased overall by 17[percnt] from FV to MRV. Among patients who were maintained on onabotulinumtoxinA during both FV and MRV, other oral prophylactic use decreased by 12.3[percnt]. CONCLUSIONS: The majority of migraineurs without a diagnosis of CM reported 15 or more headache days per month suggesting a potential underdiagnosis of CM. Patients diagnosed with CM were more likely to receive onabotulinumtoxinA than those with 蠅 15 days of headache per month with no CM diagnosis. Patients who received onabotulinumtoxinA treatment at FV and MRV showed a decrease in the use of other prophylactics suggesting a potential benefit to onabotulinumtoxinA treatment. Accurate diagnosis of migraine is vital to optimize appropriate treatment regimens for patients with this debilitating disease.

Disclosure: Dr. Reddy has received research support from Allergan, Inc. Dr. Policastro has received personal compensation for activities with Allergan, Inc. Dr. Reppine has received personal compensation for activities with Allergan, Inc. as an employee. Dr. Sekab has received research support from Allergan, Inc. Dr. Purdy has received personal compensation for activities with AHRM, Inc. as an employee. Dr. Dalfonso has received personal compensation for activities with AHRM Inc. as an employee. Dr. Magar has received personal compensation for activities with AHRM Inc. as an employee.

Tuesday, April 21 2015, 2:00 pm-6:30 pm

  • Copyright © 2015 by AAN Enterprises, Inc.

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 99 (6)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise